Compare Oscar Health Inc (OSCR) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs PepsiCo, Inc. — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while PepsiCo, Inc. trades at $125.97 (market cap $174.89B). The key difference: PepsiCo, Inc. is far larger — about 17.1× Oscar Health Inc's market cap, and PepsiCo, Inc. pays a 4.61% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and PepsiCo, Inc. for 107 Days on average.
| OSCR | PEP | |
|---|---|---|
Market Cap | $10.22B | $174.89B |
Volume | 4,123,394 | 23,968,864 |
Sector | Health | Consumer Staples |
52-Week High | $33.81 | $170.44 |
52-Week Low | $10.85 | $123.64 |
Typical Hold Time | 15 Days | 107 Days |
Enterprise Value | $6.57B | $215.61B |
Dividend Yield | — | 4.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
PepsiCo (PEP) trades at $128.88, up 4.24% today, with a bearish technical signal but strong fundamentals including a 16.14 P/E ratio and 51.59% ROE. Recent quarters show consistent earnings beats, with Q3 2026 EPS of $2.34 exceeding expectations. The company maintains robust cash flow, with 2025 operating cash flow of $12.09 billion, and announced a $1.48 dividend for H2-2026. News highlights price cuts on snacks like Doritos to address consumer pushback on high prices.
The outlook is mixed: analyst consensus targets $146.77 (14% upside) with a 'Hold' bias, but technicals suggest near-term pressure. Risks include competitive pricing pressures and debt levels, while opportunities lie in margin recovery and North American turnaround efforts. The stock offers value with a reasonable valuation and dividend yield, but requires monitoring of volume trends post-price adjustments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
